drug
METHYLPREDNISOLONE ACETATE
Marketedupdated 3mo agoby Hong Kong King-Friend Pharmaceutical Co Ltd
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6Small molecule drug with a maximum clinical stage of Approval (across all indications), with 13 approved and 9 investigational indications.
indications
investigational
Multiple SclerosisIBD (Crohn's + UC)Rheumatoid ArthritisLupusAsthma
all catalysts(41)
approval · 41
May 27, 1959
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Jul 12, 1978
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Jul 29, 1980
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Feb 17, 1981
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Mar 9, 1983
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Mar 9, 1983
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
May 12, 1986
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
May 12, 1986
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
May 12, 1986
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Jan 5, 1989
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Dec 14, 1989
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Nov 15, 1990
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Dec 28, 1993
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Jan 7, 1994
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Jan 24, 1995
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Apr 4, 2000
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
May 22, 2002
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Jan 29, 2009
approval
METHYLPREDNISOLONE ACETATE — FDA approval
METHYLPREDNISOLONE ACETATE
→
Mar 5, 2009
approval
METHYLPREDNISOLONE ACETATE — FDA approval
METHYLPREDNISOLONE ACETATE
→
Apr 7, 2009
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Apr 7, 2009
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Apr 30, 2010
approval
METHYLPREDNISOLONE ACETATE — FDA approval
METHYLPREDNISOLONE ACETATE
→
Dec 28, 2010
approval
METHYLPREDNISOLONE ACETATE — FDA approval
METHYLPREDNISOLONE ACETATE
→
Oct 7, 2013
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Oct 11, 2013
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Apr 21, 2014
approval
METHYLPREDNISOLONE ACETATE — FDA approval
METHYLPREDNISOLONE ACETATE
→
Jun 9, 2014
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Jul 3, 2014
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Sep 8, 2016
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Mar 15, 2017
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Jul 24, 2018
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Feb 11, 2021
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
May 27, 2021
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Dec 20, 2023
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Jun 5, 2024
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Feb 12, 2025
approval
METHYLPREDNISOLONE ACETATE — FDA approval
METHYLPREDNISOLONE ACETATE
→
Feb 12, 2025
approval
METHYLPREDNISOLONE ACETATE — FDA approval
METHYLPREDNISOLONE ACETATE
→
Nov 4, 2025
approval
$PFE26.79-0.04%
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Jan 20, 2026
approval
METHYLPREDNISOLONE ACETATE — FDA approval
METHYLPREDNISOLONE ACETATE
→
Jan 20, 2026
approval
METHYLPREDNISOLONE ACETATE — FDA approval
METHYLPREDNISOLONE ACETATE
→
Apr 10, 2026
approval
METHYLPREDNISOLONE ACETATE — FDA approval
METHYLPREDNISOLONE ACETATE
→
News(1)
- Opinion: The U.S. pharmaceutical supply chain problem is not about ChinaThe national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction, writes Pooja Yerramilli.stat · 21d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that